(Q36617764)

English

Multi-institutional randomized clinical study on the comparative effects of intracavital chemotherapy alone versus immunotherapy alone versus immunochemotherapy for malignant effusion

scientific article published on May 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Multi-institutional randomized clinical study on the comparative effects of intracavital chemotherapy alone versus immunotherapy alone versus immunochemotherapy for malignant effusion (English)

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Nio Y

1

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Nagami H

2

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Tamura K

3

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Tsubono M

4

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Nio M

5

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Sato M

6

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Kawabata K

7

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Hayashi H

8

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Shiraishi T

9

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Imai S

10

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Tsuchitani T

11

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Mizuta J

12

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Nakagawa M

13

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Fukumoto M

14

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

language of work or name

0 references

publication date

1 May 1999

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

British Journal of Cancer

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

80

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

5-6

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

775-785

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6690421

0 references

Reporting results of cancer treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362297

30 September 2017

Enhancement of delayed hypersensitivity reaction with varieties of anti-cancer drugs. A common biological phenomenon

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362297

30 September 2017

Advanced ovarian cancer treated by intraperitoneal immunotherapy with OK-432.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362297

30 September 2017

Intracystic injection of OK-432: a new sclerosing therapy for cystic hygroma in children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362297

30 September 2017

Early postoperative chemotherapy following noncurative resection for patients with advanced gastric cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362297

30 September 2017

Immunochemotherapy in human lung cancer using the streptococcal agent OK-432

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362297

30 September 2017

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362297

30 September 2017

Effect of Chemotherapeutic Agents on Natural Cell-Mediated Cytotoxicity in Mice2

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362297

30 September 2017

Intracavitary bleomycin in the management of malignant effusions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362297

30 September 2017

Planning the size and duration of a clinical trial studying the time to some critical event

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362297

28 June 2018

Tumor-inhibitory effect of a streptococcal preparation (NSC-B116209).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362297

28 June 2018

Animal experiments on the role of T lymphocytes in the course of antineoplastic chemotherapy. II. Chemotherapy and T lymphocyte depression.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362297

28 June 2018

Animal experiments on the role of T lymphocytes in the course of antineoplastic chemotherapy. I. Chemotherapy and tumor-specific immunity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362297

28 June 2018

Increased sensitivity of tumor cells to immune defense cells following treatment with antineoplastic agents in vitro.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362297

28 June 2018

Induction by cyclophosphamide administration of two distinct anti-tumor effector cells at tumor site and spleen of mice transplanted with MOPC-104E plasmacytoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362297

28 June 2018

Pronounced antitumor effect of LAK-like cells induced in the peritoneal cavity of mice after intraperitoneal injection of OK-432, a killed streptococcal preparation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362297

28 June 2018

Sensitivity of ovarian tumor cells to effector cells generated by various biological response modifiers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362297

28 June 2018

Intrapleural cisplatin and cytarabine in the management of malignant pleural effusions: a Lung Cancer Study Group trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362297

28 June 2018

Modulation by cis-diamminedichloroplatinum (II) of the susceptibilities of human T24 lined and freshly separated autologous urinary bladder transitional carcinoma cells to peripheral blood lymphocytes and lymphokine activated killer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362297

28 June 2018

New approach to management of malignant ascites with a streptococcal preparation, OK-432. I. Improvement of host immunity and prolongation of survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362297

20 September 2018

In vitro and in vivo effects of cisplatin on the generation of lymphokine-activated killer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/10360655

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical value of immunotherapy with the streptococcal preparation OK-432 in non-small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/10360655

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The streptococcal preparation OK-432 specifically augments the susceptibility of human urinary bladder tumor cells to autologous peripheral blood lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/10360655

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytotoxic and cytostatic effects of the streptococcal preparation OK-432 and its subcellular fractions on human ovarian tumor cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/10360655

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A GENERALIZED WILCOXON TEST FOR COMPARING ARBITRARILY SINGLY-CENSORED SAMPLES

1 reference

https://pubmed.ncbi.nlm.nih.gov/10360655

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The concept of immunochemosurgery in gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/10360655

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suppression by cytosine arabinoside of serum-blocking factors of cell-mediated immunity to syngeneic transplants of mouse mammary tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/10360655

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cellular basis for adriamycin-induced augmentation of cell-mediated cytotoxicity in culture

1 reference

https://pubmed.ncbi.nlm.nih.gov/10360655

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lysis of fresh human tumor cells by autologous peripheral blood lymphocytes and pleural effusion lymphocytes activated by OK432

1 reference

https://pubmed.ncbi.nlm.nih.gov/10360655

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of adjunctive immunotherapy in superficial bladder cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/10360655

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pseudomyxoma peritonei: effect of chronic continuous immunotherapy with a streptococcal preparation, OK-432 after surgery

1 reference

https://pubmed.ncbi.nlm.nih.gov/10360655

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A pilot study of combination therapy of radiation and local administration of OK-432 for esophageal cancer. Five-year survival and local control rate

1 reference

https://pubmed.ncbi.nlm.nih.gov/10360655

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical studies on cell-mediated immunity in patients with malignant disease. I. Effect of immunotherapy with OK-432 on lymphocyte subpopulation and phytomitogen responsiveness in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/10360655

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

OK-432-induced enhancement of ICAM-1 expression on tumor cells positively correlates to therapeutic effects for malignant effusion

1 reference

https://pubmed.ncbi.nlm.nih.gov/10360655

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of OK-432 and mitomycin C pleurodesis for malignant pleural effusion caused by lung cancer. A Randomized Trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/10360655

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neutrophil-mediated tumor cell destruction in cancer ascites

1 reference

https://pubmed.ncbi.nlm.nih.gov/10360655

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Defective monocyte killing in patients with malignancies and restoration of function during chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/10360655

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A generalized Wilcoxon test for comparing arbitrarily singly-censored samples

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690421

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690421

7 January 2021

based on heuristic

inferred from DOI database lookup

A comprehensive multi-institutional study on postoperative adjuvant immunotherapy with oral streptococcal preparation OK-432 for patients after gastric cancer surgery. Kyoto Research Group for Digestive Organ Surgery

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690421

7 January 2021

based on heuristic

inferred from DOI database lookup

An assessment of the long-term results of controlling the reaccumulation of malignant effusions using intracavity bleomycin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690421

7 January 2021

based on heuristic

inferred from DOI database lookup

A controlled study of maintenance chemoimmunotherapy vs immunotherapy alone immediately following palliative gastrectomy and induction chemoimmunotherapy for advanced gastric cancer. Tokai cooperative study group for adjuvant chemoimmunotherapy of s

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690421

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BJC.6690421

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36617764&oldid=1640784922"